|
Volumn 13, Issue 8, 2012, Pages
|
Elderly people with glioblastoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TEMOZOLOMIDE;
AGE;
AGE DISTRIBUTION;
ASTROCYTOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
CLINICAL ASSESSMENT;
CLINICAL PROTOCOL;
CLINICAL TRIAL (TOPIC);
COMORBIDITY;
DISABILITY;
DOSE RESPONSE;
ELDERLY CARE;
FOLLOW UP;
GLIOBLASTOMA;
HAZARD RATIO;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HUMAN;
KARNOFSKY PERFORMANCE STATUS;
LETTER;
LONGEVITY;
MONOTHERAPY;
ONSET AGE;
PALLIATIVE THERAPY;
PATIENT ATTITUDE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SURVIVAL PREDICTION;
SURVIVAL TIME;
TREATMENT RESPONSE;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ASTROCYTOMA;
BRAIN NEOPLASMS;
DACARBAZINE;
FEMALE;
HUMANS;
MALE;
|
EID: 84864329778
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(12)70276-0 Document Type: Letter |
Times cited : (4)
|
References (5)
|